Home/Filings/4/0001225208-22-007553
4//SEC Filing

Denton David M 4

Accession 0001225208-22-007553

CIK 0000078003other

Filed

May 31, 8:00 PM ET

Accepted

Jun 1, 5:50 PM ET

Size

9.1 KB

Accession

0001225208-22-007553

Insider Transaction Report

Form 4
Period: 2022-05-31
Denton David M
Chief Financial Officer & EVP
Transactions
  • Award

    Common Stock

    2022-05-31+61,27562,165 total
  • Award

    Stock Appreciation Rights

    2022-05-31+80,70380,703 total
    Exercise: $53.04From: 2027-05-31Exp: 2027-05-31Common Stock (80,703 underlying)
  • Award

    Stock Appreciation Rights

    2022-05-31+70,31370,313 total
    Exercise: $53.04From: 2029-05-31Exp: 2029-05-31Common Stock (70,313 underlying)
Footnotes (3)
  • [F1]The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements.
  • [F2]The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
  • [F3]The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.

Documents

1 file

Issuer

PFIZER INC

CIK 0000078003

Entity typeother

Related Parties

1
  • filerCIK 0001428718

Filing Metadata

Form type
4
Filed
May 31, 8:00 PM ET
Accepted
Jun 1, 5:50 PM ET
Size
9.1 KB